219 related articles for article (PubMed ID: 25440430)
1. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
Fuggle NR; Bragoli W; Mahto A; Glover M; Martinez AE; Kinsler VA
J Am Acad Dermatol; 2015 Jan; 72(1):108-14. PubMed ID: 25440430
[TBL] [Abstract][Full Text] [Related]
2. [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
Martel RM; Melwani P; Islas D; Peñate Y; Borrego L
Actas Dermosifiliogr; 2010 Jun; 101(5):415-20. PubMed ID: 20525484
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Meggitt SJ; Gray JC; Reynolds NJ
Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
6. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.
Murphy LA; Atherton D
Br J Dermatol; 2002 Aug; 147(2):308-15. PubMed ID: 12174104
[TBL] [Abstract][Full Text] [Related]
7. Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine.
Kuanprasert N; Herbert O; Barnetson RS
Australas J Dermatol; 2002 May; 43(2):125-7. PubMed ID: 11982569
[TBL] [Abstract][Full Text] [Related]
8. Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring.
Caufield M; Tom WL
J Am Acad Dermatol; 2013 Jan; 68(1):29-35. PubMed ID: 22892285
[TBL] [Abstract][Full Text] [Related]
9. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
Hughes R; Collins P; Rogers S
Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
[TBL] [Abstract][Full Text] [Related]
10. Monitoring recommendations for oral azathioprine, methotrexate and cyclosporin in a paediatric dermatology clinic and literature review.
Yee J; Orchard D
Australas J Dermatol; 2018 Feb; 59(1):31-40. PubMed ID: 27435804
[TBL] [Abstract][Full Text] [Related]
11. Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity.
Wee JS; Marinaki A; Smith CH
BMJ; 2011 Mar; 342():d1417. PubMed ID: 21441287
[No Abstract] [Full Text] [Related]
12. A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients.
Noguera-Morel L; Knöpfel N; Torrelo A; Hernández-Martín A
Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):227-231. PubMed ID: 30376955
[TBL] [Abstract][Full Text] [Related]
13. Retrospective review of the use of azathioprine in severe atopic dermatitis.
Lear JT; English JS; Jones P; Smith AG
J Am Acad Dermatol; 1996 Oct; 35(4):642-3. PubMed ID: 8859304
[No Abstract] [Full Text] [Related]
14. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate for treatment of atopic dermatitis in children and adolescents.
Deo M; Yung A; Hill S; Rademaker M
Int J Dermatol; 2014 Aug; 53(8):1037-41. PubMed ID: 24602088
[TBL] [Abstract][Full Text] [Related]
17. Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.
Thomsen SF; Karlsmark T; Clemmensen KK; Graversgaard C; Ibler KS; Jemec GB; Agner T
Br J Dermatol; 2015 Apr; 172(4):1122-4. PubMed ID: 25350702
[No Abstract] [Full Text] [Related]
18. The use of azathioprine in atopic dermatitis: A review.
Bracho-Borro M; Franco-Ruiz PA; Magaña M
Dermatol Ther; 2022 Sep; 35(9):e15665. PubMed ID: 35751547
[TBL] [Abstract][Full Text] [Related]
19. The use of azathioprine in severe adult atopic eczema.
Buckley DA; Baldwin P; Rogers S
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):137-40. PubMed ID: 9784039
[TBL] [Abstract][Full Text] [Related]
20. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
